BioCentury
ARTICLE | Financial News

Third Rock names Kafka venture partner

August 15, 2018 4:52 PM UTC

Third Rock Ventures named Steve Kafka venture partner. He was president and COO at cancer genomics company Foundation Medicine Inc., which Roche (SIX:ROG; OTCQX:RHHBY) acquired. Prior to that, he was COO and CFO at stapled peptide developer Aileron Therapeutics Inc. (NASDAQ:ALRN)...